{"id":"W2101725260","doi":"10.1182/blood-2014-03-560557","title":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytarabine; Hazard ratio; Internal medicine; Adverse effect; Myeloid leukemia; Confidence interval; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001675309,0.001157208,0.001625446,0.0003213342,0.0002821427,0.0009212997,0.0006102592,0.001122362,0.004074032],"category_scores_gemma":[0.001530164,0.0004324332,0.001083907,0.0002772903,0.0007926445,0.0007002341,0.0004078643,0.002773466,0.000520921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005867162,"about_ca_system_score_gemma":0.0008627808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004109167,"about_ca_topic_score_gemma":0.00142153,"domain_scores_codex":[0.9994412,0.000354457,0.00002190944,0.00008730174,0.00003323209,0.00006180781],"domain_scores_gemma":[0.9991751,0.0002782289,0.0002048419,0.00006557674,0.00003900255,0.0002371609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.952073,0.01248417,0.001341888,0.0003596946,0.0008210215,0.00006758158,0.00007184745,0.0005471689,0.007004881,0.0002559977,0.001578761,0.02339386],"study_design_scores_gemma":[0.9279348,0.06853494,0.001236751,0.00001310306,0.0002388836,0.00005030809,0.00001545773,0.0004636086,0.0005706539,0.0001582005,0.0007745731,0.000008754808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912106,0.00224174,0.000617911,0.0007967456,0.0004572025,0.002534779,0.0006992914,0.00009476515,0.001347118],"genre_scores_gemma":[0.9854215,0.001669261,0.002506691,0.001865131,0.0004014458,0.0039938,0.001381169,0.00003164439,0.002729326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004074032,"threshold_uncertainty_score":0.01362902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03015493291202409,"score_gpt":0.3241393303237978,"score_spread":0.2939843974117737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}